Concourse Financial Group Securities, Inc. Cassava Sciences Inc Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 5,866 shares of SAVA stock, worth $178,091. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,866
Previous 2,443
140.11%
Holding current value
$178,091
Previous $49,000
46.94%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SAVA
# of Institutions
184Shares Held
13.3MCall Options Held
1.38MPut Options Held
2.04M-
Black Rock Inc. New York, NY3.22MShares$97.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$81.5 Million0.0% of portfolio
-
State Street Corp Boston, MA1.18MShares$35.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA967KShares$29.4 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA691KShares$21 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $1.22B
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...